1Division of Laboratory Medicine, University of Texas M. D. Anderson Cancer Center, Houston.
Leukocyte-poor blood components (LPBC) are now standard for transfusions. They are indicated for preventing febrile reactions and cytomegalovirus (CMV) infection, despite added costs.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: